Male birth control pill moves closer to reality in new safety study
NCT ID NCT01382069
First seen Nov 20, 2025 · Last updated May 14, 2026 · Updated 18 times
Summary
This study tested a new male hormone pill called DMAU as a potential birth control for men. It involved 100 healthy men aged 18 to 50 to see if the pill is safe and how the body handles it. The study had two parts: a single dose and daily doses for 28 days. The goal is to develop a reliable male contraceptive option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Los Angeles Biomedical Research Institute
Torrance, California, 90502, United States
-
University of Washington
Seattle, Washington, 98195, United States
Conditions
Explore the condition pages connected to this study.